Junqi Niu
The First Hospital of Jilin University · The first affiliated hospital of Jilin University · First Hospital of Jilin Univerisity
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Junqi Niu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:55 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07309380 · Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis DShanghai HEP Pharmaceutical Co., Ltd. · not yet recruiting · Hepatitis D, Chronic · study chair
- N/ANCT07146100 · Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 InjectionAusper Biopharma Co., Ltd. · recruiting · Chronic Hepatitis B · principal investigator
- Ph2NCT07137910 · A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)Ausper Biopharma Co., Ltd. · recruiting · Chronic Hepatitis B · principal investigator
- Ph4NCT06743438 · Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHBJiangsu Hansoh Pharmaceutical Co., Ltd. · active not recruiting · Hepatitis B, Chronic · principal investigator
- Ph3NCT06715319 · Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · completed · PBC · principal investigator
- Ph2NCT06550128 · Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).Ausper Biopharma Co., Ltd. · completed · Hepatitis B, Chronic · principal investigator
- Ph1/Ph2NCT06115993 · A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) PatientsAusper Biopharma Co., Ltd. · completed · Hepatitis B, Chronic · principal investigator
- Ph2NCT05827146 · Study of Hepalatide in Chronic Hepatitis D(CHD) PatientsShanghai HEP Pharmaceutical Co., Ltd. · completed · Chronic Hepatitis D Infection · principal investigator
- Ph2NCT05484466 · A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHBShanghai Zhimeng Biopharma, Inc. · unknown · Hepatitis B, Chronic · principal investigator
- Ph1NCT05470829 · A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505RShanghai Zhimeng Biopharma, Inc. · completed · Healthy Volunteers, Hepatitis B, Chronic · principal investigator
- Ph1NCT05391360 · Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudySunshine Lake Pharma Co., Ltd. · completed · Hepatitis B, Chronic · principal investigator
- Ph1NCT04868981 · Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 TabletsFujian Cosunter Pharmaceutical Co. Ltd · completed · Hepatitis B · principal investigator
- Ph1NCT04701697 · Phase Ib of Recombinant Human Albumin InjectionThe First Hospital of Jilin University · completed · Ascites · study director
- Ph1NCT04641364 · Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.The First Hospital of Jilin University · completed · Ascites · study director
- N/ANCT04593355 · HCV Epidemiological Survey in China Rural AreaThe First Hospital of Jilin University · completed · Hepatitis · study chair
- Ph3NCT04543565 · Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 StudyXi'an Xintong Pharmaceutical Research Co.,Ltd. · unknown · Chronic Hepatitis b · principal investigator
- Ph1NCT04499443 · Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 TabletsFujian Cosunter Pharmaceutical Co. Ltd · unknown · Hepatitis B · principal investigator
- N/ANCT04483518 · Epidemiological Survey of Hepatitis D Virus Infection in ChinaThe First Hospital of Jilin University · completed · Observe and Describe the Prevalence of Hepatitis D Infection Among HBsAg Positive People · study director
- Ph1NCT04386915 · Study on the Tolerance and Pharmacokinetics of GST-HG141 TabletsFujian Cosunter Pharmaceutical Co. Ltd · unknown · Hepatitis B · principal investigator
- Ph1/Ph2NCT04202952 · The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected SubjectsSunshine Lake Pharma Co., Ltd. · completed · Chronic Hepatitis C · principal investigator
- Ph2NCT04157699 · An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis bQilu Pharmaceutical Co., Ltd. · unknown · Chronic Hepatitis b · principal investigator
- Ph2NCT04157257 · An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyQilu Pharmaceutical Co., Ltd. · unknown · Chronic Hepatitis b · principal investigator
- Ph2NCT04147208 · Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV InfectionSunshine Lake Pharma Co., Ltd. · completed · Chronic HBV Infection · principal investigator
- Ph2/Ph3NCT04070235 · SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis CNanjing Sanhome Pharmaceutical, Co., Ltd. · unknown · Hepatitis C, Chronic · principal investigator
- Ph3NCT03995485 · KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis CKawin Technology Share-holding Co., Ltd. · completed · Hepatitis C, Chronic · principal investigator
- Ph2NCT03638076 · The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesSunshine Lake Pharma Co., Ltd. · completed · Chronic Hepatitis B · principal investigator
- N/ANCT03546530 · The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsThe First Hospital of Jilin University · completed · Hepatitis B, Interferon · principal investigator
- N/ANCT03509688 · The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical TrialThe First Hospital of Jilin University · completed · Hepatitis · study chair
- N/ANCT02961413 · A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)Drug Induced Liver Disease Study Group · recruiting · Drug-induced Liver Injury · principal investigator
- N/ANCT02476695 · FibroTouch Non-invasive Evaluation of Liver Fibrosis and CirrhosisWuxi Hisky Medical Technology Co Ltd · completed · Liver Fibrosis, Cirrhosis, Chronic Hepatitis B · principal investigator
- Ph1/Ph2NCT01997944 · Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsBeijing Bio-Fortune Ltd. · completed · Chronic Hepatitis B · principal investigator
- N/ANCT01434212 · Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon TherapyThe First Hospital of Jilin University · unknown · Hepatitis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:55 UTC. The ranking covers the 200 most relevant of 176 PubMed records, and a shared surname and initials can bring in a namesake. All 176 on PubMed
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.N Engl J Med · 20181,131 citationsRCR 39.6
- 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.Gastroenterology · 2009454 citationsRCR 13.0
- 248 citationsRCR 14.6
- Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.N Engl J Med · 2025205 citationsRCR 59.8
- Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.Lancet Gastroenterol Hepatol · 2019193 citationsRCR 10.4
- Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.J Hepatol · 2017168 citationsRCR 8.1
- The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis.Arthritis Rheum · 2005166 citationsRCR 5.9
- 147 citationsRCR 7.8
- Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.Hepatology · 2008140 citationsRCR 3.8
- 126 citationsRCR 4.9